ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,127.79
      1.26%
      US Tech 100
      17,446.00
      2.17%
      Dow Jones
      38,675.68
      1.18%
      Brent Oil
      82.765
      0.00%
      Bitcoin
      63,823.69
      1.49%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. Emergent Biosolutions Inc (EBS)

      7. Emergent Biosolutions Inc (EBS) News

      EBS

      Emergent Biosolutions (EBS)

      Emergent Biosolutions Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NYSE:EBS
      DateTimeSourceHeadlineSymbolCompany
      05/01/20244:57PMGlobeNewswire Inc.Emergent BioSolutions Reports First Quarter 2024 Financial ResultsNYSE:EBSEmergent Biosolutions Inc
      05/01/20244:10PMGlobeNewswire Inc.Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial PositionNYSE:EBSEmergent Biosolutions Inc
      05/01/202411:03AMGlobeNewswire Inc.Emergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to NaloxoneNYSE:EBSEmergent Biosolutions Inc
      04/30/20245:26PMGlobeNewswire Inc.Emergent BioSolutions Announces Amendment to its Existing Credit FacilityNYSE:EBSEmergent Biosolutions Inc
      04/22/20248:05AMGlobeNewswire Inc.Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024NYSE:EBSEmergent Biosolutions Inc
      04/01/20248:00AMGlobeNewswire Inc.Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech ExecutiveNYSE:EBSEmergent Biosolutions Inc
      03/28/20248:15AMGlobeNewswire Inc.Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid CrisisNYSE:EBSEmergent Biosolutions Inc
      03/25/20248:05AMGlobeNewswire Inc.Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing FacilityNYSE:EBSEmergent Biosolutions Inc
      03/08/20244:21PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:EBSEmergent Biosolutions Inc
      03/07/20248:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
      03/06/20244:31PMGlobeNewswire Inc.Emergent BioSolutions Reports Fourth Quarter 2023 Financial ResultsNYSE:EBSEmergent Biosolutions Inc
      03/06/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:EBSEmergent Biosolutions Inc
      03/06/20246:02AMIH Market NewsU.S. Stock Futures Gain Ahead of Economic Insights; Oil Prices ClimbNYSE:EBSEmergent Biosolutions Inc
      03/04/20246:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
      03/04/20246:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
      03/04/20246:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
      02/29/20247:00AMGlobeNewswire Inc.Emergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results, and Conduct Conference Call on March 6, 2024NYSE:EBSEmergent Biosolutions Inc
      02/27/20248:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
      02/27/20248:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
      02/21/20247:25AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:EBSEmergent Biosolutions Inc
      02/21/20247:00AMGlobeNewswire Inc.Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEONYSE:EBSEmergent Biosolutions Inc
      01/11/20247:41AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:EBSEmergent Biosolutions Inc
      01/09/20248:40AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:EBSEmergent Biosolutions Inc
      01/09/20247:30AMGlobeNewswire Inc.Emergent BioSolutions to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024NYSE:EBSEmergent Biosolutions Inc
      12/27/20236:08AMIH Market NewsWall Street Highlights: Apple Appeals Watch Ban, Tesla to Launch Updated Model Y, and MoreNYSE:EBSEmergent Biosolutions Inc
      12/11/20235:22PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:EBSEmergent Biosolutions Inc
      12/11/20237:24AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:EBSEmergent Biosolutions Inc
      11/28/20237:15AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:EBSEmergent Biosolutions Inc
      11/28/20236:59AMGlobeNewswire Inc.Emergent BioSolutions Receives $75 Million Contract Option from BARDA to Procure Doses of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted)NYSE:EBSEmergent Biosolutions Inc
      11/24/20237:30AMGlobeNewswire Inc.Emergent BioSolutions Receives NYSE Notice Regarding Delayed Form 10-Q FilingNYSE:EBSEmergent Biosolutions Inc
       Showing the most relevant articles for your search:NYSE:EBS